Cheminformatic Tools and Databases for Pharmacology

session 91442 - Total of 3 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
TENOFOVIR (is an active metabolite)

TENOFOVIR


ATC J05AF07
ATC J05AR03
ATC J05AF13
ATC J05AR06
ATC J05AR08
ATC J05AR12
ATC J05AR24
ATC J05AR11
ATC J05AR27

ANTIINFECTIVE
ANTIVIRAL
ANTIRETROVIRAL
NUCLEOTIDE ANALOG HIV-1 REVERSE TRANSCRIPTASE INHIBITOR AND
HBV REVERSE TRANSCRIPTASE INHIBITOR
CHRONIC HEPATITIS B IN ADULTS

-

Cmax 0.578 MICROMOLAR (300 MILLIGRAM)

F 25 PERCENT

VD 84.5 LITER (65 KILOGRAM)

PPB 7 PERCENT

Cl 3.4 LITER / HOUR (EQN)

HT 17 HOUR

HIV REVERSE TRANSCRIPTASE

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE INHIBITOR CHEMBL247 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE Q72547 REVERSE TRANSCRIPTASE/RNASEH HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME HYDROLASEEMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
TENOFOVIR ALAFENAMIDE (has an active metabolite)

TENOFOVIR ALAFENAMIDE


ATC J05AR17
ATC J05AF13
ATC J05AR20
ATC J05AR19

ANTIINFECTIVES
TREATMENT OF HIV-1 INFECTION
CONVERTED IN VIVO TO TENOFOVIR

ORAL

Cmax 0.33 MICROMOLAR

Tmax 1 HOUR

PPB 80 PERCENT

HT 0.51 HOUR

SOLUBILITY 4.7 MILLIGRAM / MILLILITER

HIV REVERSE TRANSCRIPTASE

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE INHIBITOR CHEMBL247 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE Q72547 REVERSE TRANSCRIPTASE/RNASEH HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME HYDROLASEEMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

3 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
TENOFOVIR DISOPROXIL (has an active metabolite)

TENOFOVIR DISOPROXIL


ATC J05AF07
ATC J05AR03
ATC J05AR06
ATC J05AR08
ATC J05AR12
ATC J05AR24
ATC J05AR11
ATC J05AR27

ANTIINFECTIVE
ANTIVIRAL
ANTIRETROVIRAL
NUCLEOTIDE ANALOG HIV-1 REVERSE TRANSCRIPTASE INHIBITOR AND
HBV REVERSE TRANSCRIPTASE INHIBITOR
CHRONIC HEPATITIS B IN ADULTS

ORAL

SOLUBILITY 13.4 MILLIGRAM / MILLILITER

HIV REVERSE TRANSCRIPTASE

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE INHIBITOR CHEMBL247 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE Q72547 REVERSE TRANSCRIPTASE/RNASEH HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME HYDROLASEEMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |